JPRN-jRCT2080221142未知2 期
The early Phase 2 clinical study of JTS-653 in Post-Herpetic Neuralgia
JAPAN TABACCO INC.0 个研究点目标入组 160 人开始时间: 2010年6月30日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •The patient who passed for 3 months or more after the herpes zoster onset.
排除标准
- •The patient who has other chronic pains in the PHN affected part
研究者
相似试验
未知
1 期
Phase 1 Clinical Study of JTS-661 - Pharmacokinetic Study in Patients on HemodialysisJapanese patients with CKD on maintenance hemodialysisJPRN-jRCT2080223686JAPAN TABACCO INC.6
未知
2 期
Early Phase 2 Clinical Study of JTS-661 - Efficacy and Safety StudyPruritusJPRN-jRCT2080223725JAPAN TABACCO INC.240
已完成
不适用
A phase III open clinical study of SJP-0118 in patients who schedule intraocular surgeryJPRN-UMIN000026494Senju Pharmaceutical Co.,Ltd.150
招募中
2 期
Dose finding study of JTE-051Interstitial Cystitis/Bladder Pain SyndromeJPRN-jRCT2031210042Koretomo Ryosuke150
未知
2 期
Phase 2 Dose-Finding Study of JTT-305 in Patients with Primary Osteoporosis.JPRN-jRCT2080220803JAPAN TABACCO INC.320